ReviewJournal of nanobiotechnology2025
Ultrasound-responsive micro/nanobubbles based intelligent theranostic systems for precision tumor therapy.
Review in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Pathway-specific mechanisms, therapeutic applications, and toxicodynamic profile of acriflavine in cancer: a comprehensive review.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- Review
- Acoustic delivery of indocyanine green via biosynthetic gas vesicles for tumor photothermal therapy.PLoS biology · 2026Article
- Emerging Nanoplatforms are Effective Against Tumor Hypoxia.International journal of nanomedicine · 2026Review
- Shikonin in Hepatocellular Carcinoma: Bridging Metabolic Disruption and Immunomodulation.Journal of hepatocellular carcinoma · 2026Review
- Bioengineering Strategies to Address Key Bottlenecks in Ferroptosis-Based Cancer Therapy: A Critical Review.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Ultrasound-targeted micro/nanobubble cavitation (UTMC/UTNC) has emerged as a highly promising ultrasound-based strategy for precision tumor therapy. This technique harnesses microbubbles and nanobubbles as cavitation nuclei that respond to ultrasound, inducing cavitation effects, generating mechanical forces that transiently permeabilize biological barriers, enhance vascular and cellular permeability, and induce localized tumor cell disruption. These cavitation-mediated effects enable spatiotemporally controlled drug release, markedly improving intratumoral drug accumulation and maximizing therapeutic efficacy while reducing systemic toxicity. This review provides a comprehensive overview of the mechanistic foundations and therapeutic applications of UTMC/UTNC. The physical mechanisms by which bubbles act as cavitation nuclei, undergoing oscillation, expansion, collapse, or rupture under ultrasound stimulation, and their resulting biological effects are discussed in detail. Furthermore, emphasizing the roles of UTMC/UTNC in enhancing chemotherapy, sonodynamic therapy, immunotherapy, gene delivery, radiotherapy, and ferroptosis is reviewed. These therapeutic enhancements are primarily attributed to improved drug delivery and cavitation-induced tumor cell disruption. Finally, key challenges and limitations associated with UTMC/UTNC-mediated tumor therapy are discussed, along with prospects for clinical translation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.